<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date22171033.8 (espacenet)  (Federated)  (European Patent Register), 20190422
Patent/reg. no. and dateDK/EP 4056176, 20240424
Publication date20220914
Priority no. and dateUS 201862735670 P, 20180924, US 201862735680 P, 20180924, US 201862758387 P, 20181109, US 201962813888 P, 20190305, US 201962818514 P, 20190314
EP pub. no. and date EP 4056176 20220914
Effective date
Applicant/ownerAmarin Pharmaceuticals Ireland Limited, 88 Harcourt Street
Dublin
D02 DK18 Dublin2, IE
Applicant ref. no.V475612DK00
InventorSONI, Paresh,
Mystic, 06355, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/202 (2006.01) , A61K 31/232 (2006.01) , A61K 31/366 (2006.01) , A61K 31/40 (2006.01) , A61K 31/505 (2006.01) , A61K 45/06 (2006.01) , A61K 47/06 (2006.01) , A61P 9/00 (2006.01) , A61P 9/10 (2006.01) 
TitleFremgangsmåde til at reducere risikoen af kardiovaskulære hændelser hos et individ
Int. application no.
Int. publication no.
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact